MUHAMMAD SHAHBAKHT
Prescription History 1407303621
Optometrist in Iselin, NJ
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MUHAMMAD SHAHBAKHT, an active Optometrist specialist practicing in Iselin, NJ. Our medical registry currently tracks 10 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 568 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 190 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other NJ PrescribersVs. NJ Avg |
|---|---|---|---|
| Latanoprost | 190 | $10.57▼ below NJ avg | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2024, this provider wrote 190 Medicare prescriptions for Latanoprost, about 1.5 times the volume of the typical New Jersey prescriber of this medication (126.6). Medicare paid an average of $10.57 per fill, versus $12.45 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 310.9 30-Day Fills standardized to 30-day supplies 8,908 Days of Medication total across all patients in 2024 | |||
| Timolol Maleate | 80 | $24.65▼ below NJ avg | ≈ Typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2024, this provider wrote 80 Medicare prescriptions for Timolol Maleate, about 1.2 times the volume of the typical New Jersey prescriber of this medication (65.9). Medicare paid an average of $24.65 per fill, versus $25.68 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 108 30-Day Fills standardized to 30-day supplies 3,024 Days of Medication total across all patients in 2024 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 78 | $13.65▼ below NJ avg | ≈ Typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2024, this provider wrote 78 Medicare prescriptions for Dorzolamide-Timolol, about the same volume as the typical New Jersey prescriber of this medication (82.9). Medicare paid an average of $13.65 per fill, versus $18.49 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 139.9 30-Day Fills standardized to 30-day supplies 4,192 Days of Medication total across all patients in 2024 | |||
| Prednisolone Acetate | 53 | $47.89 | ▼ Less than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. In 2024, this provider wrote 53 Medicare prescriptions for Prednisolone Acetate, about half the volume of the typical New Jersey prescriber of this medication (120.6). Medicare paid an average of $47.89 per fill, versus $39.79 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 69.1 30-Day Fills standardized to 30-day supplies 1,728 Days of Medication total across all patients in 2024 | |||
| Ketorolac Tromethamine | 52 | $27.85 | ▼ Less than typical |
About Ketorolac Tromethamine: This medication is used to temporarily relieve itching eyes caused by seasonal allergies. Show more ▾ It is also used to prevent and treat eye swelling due to a certain type of eye surgery (cataract removal). Ketorolac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances in your body to reduce pain and swelling. A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is a non-steroidal anti-inflammatory agent used for analgesia for postoperative pain and inhibits cyclooxygenase activity. In 2024, this provider wrote 52 Medicare prescriptions for Ketorolac Tromethamine, about 61% of the volume of the typical New Jersey prescriber of this medication (84.7). Medicare paid an average of $27.85 per fill, versus $21.80 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 68.6 30-Day Fills standardized to 30-day supplies 1,809 Days of Medication total across all patients in 2024 | |||
| Brimonidine Tartrate | 35 | $56.86▼ below NJ avg | ▼ Less than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 35 Medicare prescriptions for Brimonidine Tartrate, about 60% of the volume of the typical New Jersey prescriber of this medication (57.9). Medicare paid an average of $56.86 per fill, versus $63.07 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 51.4 30-Day Fills standardized to 30-day supplies 1,502 Days of Medication total across all patients in 2024 | |||
| LumiganBimatoprost | 23 | $427.25▼ below NJ avg | ▼ Less than typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 23 Medicare prescriptions for Lumigan, about a third of the volume of the typical New Jersey prescriber of this medication (62.7). Medicare paid an average of $427.25 per fill, versus $498.05 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 38.3 30-Day Fills standardized to 30-day supplies 1,058 Days of Medication total across all patients in 2024 | |||
| MoxifloxacinMoxifloxacin Hcl | 23 | $29.66 | ▼ Less than typical |
About Moxifloxacin: This medication is a quinolone antibiotic used for eye infections. Show more ▾ A fluoroquinolone that acts as an inhibitor of DNA TOPOISOMERASE II and is used as a broad-spectrum antibacterial agent. In 2024, this provider wrote 23 Medicare prescriptions for Moxifloxacin, about a third of the volume of the typical New Jersey prescriber of this medication (79.8). Medicare paid an average of $29.66 per fill, versus $20.88 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 27.5 30-Day Fills standardized to 30-day supplies 501 Days of Medication total across all patients in 2024 | |||
| CombiganBrimonidine Tartrate/Timolol | 22 | $368.95 | ▼ Less than typical |
About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2024, this provider wrote 22 Medicare prescriptions for Combigan, about 63% of the volume of the typical New Jersey prescriber of this medication (35.1). Medicare paid an average of $368.95 per fill, versus $368.62 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 40.2 30-Day Fills standardized to 30-day supplies 1,162 Days of Medication total across all patients in 2024 | |||
| XiidraLifitegrast | 12 | $703.15▼ below NJ avg | ▼ Less than typical |
About Xiidra: This medication is used to treat dry eye disease. Show more ▾ An LFA-1 (LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1) antagonist that is used in the treatment of DRY EYE SYNDROMES. In 2024, this provider wrote 12 Medicare prescriptions for Xiidra, about a third of the volume of the typical New Jersey prescriber of this medication (40.8). Medicare paid an average of $703.15 per fill, versus $1,148.13 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for MUHAMMAD SHAHBAKHT is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Iselin, NJ practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among NJ prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
